Indegene, a healthcare tech firm, has acquired BioPharm, a specialized marketing agency, for $106 million. The deal aims to boost Indegene’s AI-led pharma marketing portfolio and expand its capabilities for global pharmaceutical companies. BioPharm has a strong client roster, including 17 of the top 25 biopharma companies, and offers expertise in omnichannel strategy and targeted engagement.